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HIV-1 infection leads to T cell dysfunction and apoptosis in vivo and in vitro. The shared common g chain of IL-2R and its
associated Janus kinase, JAK3, are indispensable for normal T cell function and survival. We have reported that CD4 ligation
with HIV gp120 inhibits T cell receptor-induced activation and expression of JAK3. We have also shown that while some
strains of HIV-1, such as NL4-3, induce apoptosis of infected CD41 T cells, other strains, such as HIV-1 IIIB, do not.
Interestingly, we show here that infection of CD41 T cells with HIV-1 NL4-3, but not IIIB, inhibited activation and expression
of JAK3. NL4-3-infected T cells were unable to upregulate JAK3 expression following stimulation through TCR/CD3. In
addition, NL4-3, but not IIIB, inhibited tyrosine phosphorylation and expression of STAT5, a downstream target of JAK3. These
data suggest a correlation between apoptosis of HIV-1-infected T cells and inhibition of the JAK3/STAT5 activation pathway.
© 2001 Academic Press
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T cell dysfunction and apoptosis in HIV disease are
thought to be the result of direct viral cytopathicity in
infected cells and of indirect effects of viral particles
and/or gene products on bystander cells (Finkel et al.,
1995; Gandhi et al., 1998; Herbein et al., 1998). Ligation of
the CD4 receptor with HIV gp120 or anti-CD4 mAb inhib-
its T cell receptor (TCR)/CD3-induced activation and in-
duces apoptosis in resting T cells (Banda et al., 1992;
Liegler and Stites, 1994). The biochemical mechanisms
of HIV-1-induced T cell dysfunction and apoptosis are not
understood. Recently, we have shown that increases in
JAK3 expression and activation induced by antigen re-
ceptor ligation are inhibited by prior CD4 ligation by HIV
gp120 or anti-CD4 mAb (Selliah and Finkel, 1998). These
data suggest that, at least in this in vitro system, binding
of CD4 by HIV gp120 downregulates activation-induced
transcriptional regulation and activation of JAK3 and its
target signal transducer and activator of transcription
(STATs). In vivo evidence for inhibition of the JAK/STAT
pathway in HIV disease comes from data of Pericle et al.
(1998). The authors observed a selective reduction of
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412STAT5B expression in HIV-infected PBMC and reduced
expression of STAT1a, STAT5A, and STAT5B in T cells
from HIV-seropositive individuals. Collectively, these
data argue that T cell dysfunction and apoptosis in HIV
disease may be due, in part, to aberrant regulation of the
JAK3/STAT5 signaling pathway.
We and others have reported that HIV-1 induces apo-
ptosis of infected CD41 T cells (Nardelli et al., 1995;
Rapaport et al., 1998). Specifically, we have shown that T
cells infected with HIV-1 NL4-3 undergo apoptosis, lead-
ing to the elimination of productively infected cells in the
culture (Rapaport et al., 1998). In contrast, levels of apo-
ptosis in infected cells from IIIB-infected cultures are
significantly less than from NL4-3-infected cultures, lead-
ing to persistence of in vitro infection. Surprisingly, the
frequency of apoptotic IIIB-infected cells is even less
than that seen in uninfected cultures (Rapaport et al.,
1998). The biochemical mechanisms involved in inhibi-
tion of apoptosis by HIV-1 IIIB are not understood.
The JAK3/STAT5 signaling pathway has been shown to
play a major role in the proliferation and survival of T
cells. Studies of genetically deficient mice showed that
JAK3 is absolutely essential for common g-chain (gc)-
dependent T cell development and gc-dependent preven-
tion of thymocyte apoptosis (Sohn et al., 1998; Suzuki et
al., 2000; Thomis et al., 1997). Peripheral T cells from
JAK3-deficient mice have increased susceptibility to ap-
optosis and do not proliferate after in vitro stimulation
with antigens or mitogens (Sohn et al., 1998; Thomis and
Berg, 1997; Thomis et al., 1997). Studies of STAT5-defi-
cient mice show that STAT5 is specifically required for
cell cycle progression in response to TCR ligation and
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413HIV-1 INFECTION AND JAK3/STAT5 ACTIVATIONIL-2 receptor activation (Moriggl et al., 1999). STAT5 is a
critical component of the IL-2 receptor-mediated prolif-
erative signal and regulates expression of both mito-
genic and survival genes (Lord et al., 2000; Zamorano et
al., 1998). Since HIV gp120-induced T cell dysfunction
and apoptosis are correlated with inhibition of JAK3 ex-
pression and activation, we investigated the effect of
NL4-3 and IIIB infection on the JAK3/STAT5 activation
pathway.
RESULTS
NL4-3, but not IIIB, inhibits activation and expression
of JAK3
CD4 ligation with HIV gp120 inhibits T cell receptor-
induced activation and expression of JAK3 (Selliah and
Finkel, 1998). Here, we investigated the effect of HIV-1
NL4-3 and IIIB infection of JAK3 activation and expres-
sion in CD41 T cells. Phytohemagglutinin (PHA)-acti-
ated CD41 T cells were infected with NL4-3 or IIIB, and
AK3 activation was determined as described under Ma-
erials and Methods. Briefly, postnuclear lysates were
mmunoprecipitated with anti-JAK3 antibody and immu-
oblotted with anti-phosphotyrosine antibody. JAK3 is
ctivated following cytokine binding to the cytokine re-
eptor by autophosphorylation on a tyrosine residue
FIG. 1. NL4-3, but not IIIB, inhibits JAK3 activation and expression. (A
ay 6, cells were harvested and lysed and postnuclear supernatants we
mmunoblotted (IB) with anti-phosphotyrosine antibody (P-Tyr, top) and
ach band was determined and the ratio of P-Tyr/JAK3 was plotted. p2
representative experiment of five performed is shown. (B) JAK3 expre
nalyzed by immunoblotting with anti-JAK3 pAb (top) and then stripped
etermined and change (increase or decrease) in JAK3 protein level
alculated as described under Materials and Methods. The blot shown
f five experiments. The asterisk represents a significant difference bJohnston et al., 1994). NL4-3 infection of T cells inhibited
the activation of JAK3 (Fig. 1A). Interestingly, anotherHIV-1 T cell-tropic virus strain, IIIB, did not inhibit the
activation of JAK3 (Fig. 1A). The optical density ratios of
tyrosine-phosphorylated JAK3 to total JAK3 protein con-
firm that NL4-3 infection markedly inhibits JAK3 activa-
tion. Numbers of productively infected cells in NL4-3 and
IIIB cultures were similar (45 and 35% p24gag1 cells,
respectively).
Similar experiments were done to determine the ex-
pression of JAK3 in NL4-3- or IIIB-infected T cells. JAK3
expression was determined by separating postnuclear
lysates on a SDS–PAGE gel and immunoblotting with
anti-JAK3 antibody and then with anti-actin mAb. The
optical density of each band was measured and the ratio
of JAK3/actin was graphed. NL4-3 infection significantly
inhibited JAK3 expression in T cells (Fig. 1B). Interest-
ingly, JAK3 levels in IIIB infected cells were similar to the
levels in uninfected cells (Fig. 1B). These data show that
NL4-3, but not IIIB, inhibits activation and expression of
JAK3, one of the kinases necessary for T cell proliferation
and survival.
NL4-3, but not IIIB, inhibits TCR/CD3-induced JAK3
expression
Resting T cells have very low levels of JAK3 protein,
which increases with activation through the TCR/CD3
complex by an IL-2 receptor-independent mechanism
activation. CD41 T cells were infected with HIV-1 NL4-3 or IIIB, and at
unoprecipitated (IP) with anti-JAK3 pAb. Nitrocellulose membrane was
ripped and immunoblotted with anti-JAK3 antibody (bottom). The OD of
lls in NL4-3- and IIIB-infected cultures were 45 and 35%, respectively.
D41 T cells were infected with NL4-3 or IIIB as in A. Cell lysates were
munoblotted with anti-actin mAb (bottom). The OD of each band was
infected T cells was compared to the level in uninfected T cells and
epresentative experiment of five and the graph is the average 6 SEM
NL4-3 and IIIB (P 5 0.05).) JAK3
re imm
then st
4gag1 ce
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is a r(Johnston et al., 1994). As shown above, PHA-activated T
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414 SELLIAH AND FINKELcontrol T cells), although NL4-3 infection of these cells
led to a decrease in JAK3 expression (Fig. 1B). Experi-
ments were done to determine whether these NL4-3-
infected T cells could increase JAK3 expression follow-
ing stimulation through the TCR/CD3 with anti-CD3 mAb.
Four days after infection with NL4-3 or IIIB, T cells were
either unstimulated or stimulated with anti-CD3 mAb for
24 h. The cells were then harvested, lysed, and analyzed
by SDS–PAGE. The nitrocellulose membrane was blotted
with anti-JAK3 pAb and then with anti-actin mAb. In T
cells cultured without stimulation for 24 h, the JAK3
protein decreased to undetectable levels. In contrast,
anti-CD3 mAb stimulation of uninfected T cells signifi-
cantly increased JAK3 expression (Fig. 2A). Anti-CD3
mAb also induced JAK3 expression in IIIB-infected T
cells, to levels similar to those seen in uninfected cells.
Interestingly, NL4-3-infected T cells showed no increase
in JAK3 expression following anti-CD3 mAb stimulation
(Figs. 2A and 2B). These data suggest that NL4-3-in-
fected T cells are defective in activation-induced JAK3
expression.
Inhibition of JAK3 expression correlates with
apoptosis in NL4-3-infected T cells
JAK3 has been shown to play a major role in the T cell
FIG. 2. NL4-3, but not IIIB, inhibits TCR/CD3-induced JAK3 expressio
were either unstimulated (Unstim.) or stimulated with anti-CD3 mAb fo
immunoblotted with anti-JAK3 pAb (top) and then with anti-actin mAb (b
plotted. The percentages p24gag1 cells were NL4-3, unstimulated, 20
representative experiment of three performed is shown. (B) Change in JA
and uninfected T cells, calculated for each experiment, as described u
The asterisk represents a significant difference between NL4-3 and IIproliferation and survival of T cells (Kirken et al., 1995).
As discussed above, NL4-3, but not IIIB, inhibits JAK3 pexpression and activation. In order to determine the
correlation between JAK3 expression and apoptosis in
HIV-infected T cells, the change (increase or decrease)
in JAK3 protein level in HIV-infected T cells was com-
pared to the level in uninfected T cells and calculated for
each experiment as described under Materials and
Methods. The percentage apoptotic cells and percent-
age p241 cells were also compared. Significant inhibi-
ion of JAK3 expression and increases in apoptosis were
een after day 6 of NL4-3 infection and were significantly
ifferent between NL4-3 and IIIB (Fig. 3). In IIIB-infected
cells, no inhibition of JAK3 expression and very low
evels of apoptosis were seen. Intriguingly, the JAK3
rotein level was higher in IIIB-infected cells than in
ninfected cells. We have reported previously that IIIB-
nfected T cells show less apoptosis than uninfected
ontrol T cells (Rapaport et al., 1998). These data show a
orrelation between JAK3 expression and apoptosis. Fur-
her experiments are in progress to directly demonstrate
he effect of JAK3 in HIV-induced and spontaneous apo-
tosis.
L4-3 inhibits activation, but not expression, of JAK1;
L4-3 does not affect expression or activation of
AK2
D41 T cells were infected with HIV-1 NL4-3 or IIIB for 4 days and cells
Cells were harvested and lysed and postnuclear supernatants were
The OD of each band was determined and the ratio of JAK3/actin was
-CD3 mAb, 46.4; and IIIB, unstimulated, 13.9; anti-CD3 mAb, 46.8. A
tein level in response to anti-CD3 mAb was determined for HIV-infected
aterials and Methods. Average 6 SEM of three experiments is shown.
0.0005).n. (A) C
r 24 h.
ottom).
.6; anti
K3 proJAK1, like JAK3, associates with the IL-2 receptor com-
lex (Russell et al., 1994). Experiments were done to
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415HIV-1 INFECTION AND JAK3/STAT5 ACTIVATIONdetermine whether NL4-3 inhibits activation and expres-
sion of other Janus family kinases, JAK1 and JAK2. PHA-
activated CD41 T cells were infected with HIV-1 NL4-3 or
IIB and activation and expression of JAK1 and JAK2 were
etermined as described under Materials and Methods.
s shown in Fig. 4A, moderate inhibition of JAK1 activa-
ion was seen in NL4-3- but not IIIB-infected T cells. This
s intriguing, given recent data suggesting that JAK3
hosphorylates JAK1 (Zhou et al., 2000). In contrast to
AK3, NL4-3 infection did not inhibit the expression of
AK1 (Fig. 4C). No inhibition of JAK2 activation or expres-
ion was seen in NL4-3- or IIIB-infected T cells (Figs. 4B
nd 4C). These data suggest that NL4-3 does not induce
FIG. 3. Inhibition of JAK3 expression correlates with apoptosis in
L4-3-infected T cells. Change (increase or decrease) in JAK3 protein
evel in HIV-infected T cells (day 4 and day 6 postinfection) was
ompared to the level in uninfected T cells and calculated for each
xperiment as described under Materials and Methods (top). Aver-
ge 6 SEM of four experiments is shown. Percentage apoptotic cells
was determined with FS/SS analysis for each experiment and aver-
age 6 SEM of four experiments is shown (bottom). The percentages
p24gag1 cells, averages 6 SEM of four experiments, were day 4, NL4-3,
40.25 6 5.13; IIIB, 17.73 6 5.57; and day 6, NL4-3, 25.00 6 8.63; IIIB 5
5.85 6 4.22. The asterisks represent significant differences between
L4-3 and IIIB (P , 0.05).global inhibition of the JAKs, but may specifically target
he JAK3 activation pathway.
r
cL4-3, but not IIIB, inhibits phosphorylation and
xpression of STAT5
STAT5 is one of the substrates for JAK3, and tyrosine
hosphorylation of STAT5 is required for its function as a
ranscription factor (Darnell, 1997). As with JAK3, STAT5
s required for T cell proliferation and survival (Lord et al.,
000; Moriggl et al., 1999; Zamorano et al., 1998). Since
nfection of T cells with NL4-3, but not IIIB, inhibited JAK3
ctivation, we investigated the phosphorylation status of
TAT5 in these cells. PHA-activated CD41 T cells were
infected with HIV-1 NL4-3 or IIIB, and STAT5 phosphor-
ylation was determined as described under Materials
and Methods. Briefly, postnuclear lysates were immuno-
precipitated with anti-STAT5 antibody and immunoblot-
ted with anti-phosphotyrosine antibody. NL4-3 infection
inhibited the tyrosine phosphorylation of STAT5 (Fig. 5A).
As expected, IIIB did not inhibit the tyrosine phosphory-
lation of STAT5. The optical density ratio of tyrosine-
phosphorylated STAT5 to total STAT5 protein confirms
that NL4-3 markedly inhibits STAT5 phosphorylation.
Numbers of productively infected cells in NL4-3 and IIIB
cultures were similar (45 and 35% p24gag1 cells, respec-
ively).
Similar experiments were done to determine the ex-
ression of STAT5 in NL4-3- or IIIB-infected T cells.
TAT5 expression was determined by separating post-
uclear lysates by SDS–PAGE and immunoblotting with
nti-STAT5 pAb and then with anti-actin mAb. The optical
ensity of each band was measured and the ratio of
TAT5/actin was graphed. NL4-3, but not IIIB, inhibited
TAT5 expression in T cells (Fig. 5B). Anti-STAT5 pAb
ecognizes both STAT5a and STAT5b isoforms; as shown
n Fig. 5B, neither was detected in NL4-3-infected T cells.
hese data provide further evidence that NL4-3, but not
IIB, inhibits the JAK3/STAT5 activation pathway.
Although in a few experiments, JAK3 and STAT5 pro-
eins were completely absent in NL4-3-infected cells, in
majority of experiments, small amounts of JAK3 and
TAT5 protein could be detected. We asked whether this
mall amount of JAK3 could be activated to phosphory-
ate its substrate, STAT5, by the addition of a higher
oncentration of IL-2. This experiment was done to in-
rease the sensitivity of the assay to detect phosphory-
ated STAT5, thereby indirectly determining the activation
tatus of JAK3. T cells from uninfected or NL4-3- or
IIB-infected cultures were incubated without or with 50
/ml IL-2 for 15 min at 37°C. Whole-cell lysates were
eparated by SDS–PAGE and immunoblotted with the
ndicated antibodies. Addition of IL-2 significantly in-
reased the phosphorylation of STAT5 in uninfected or
IIB-infected T cells (Fig. 6A). In contrast, T cells from
L4-3 infection did not show any detectable phosphor-
lated STAT5 (Fig. 6). Longer exposure of the blot did not
eveal any phosphorylated STAT5 in NL4-3-infected T
ells (Fig. 6B, pSTAT5—longer exposure). Measurement
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416 SELLIAH AND FINKELof the ratio of pSTAT5/STAT5 OD showed that phosphor-
FIG. 4. NL4-3 inhibits activation, but not expression, of JAK1; NL4-3
cells were infected with HIV-1 NL4-3 or IIIB, and at day 6, cells were h
(IP) with anti-JAK1 pAb. Nitrocellulose membrane was immunoblotted
immunoblotted with anti-JAK1 antibody (bottom). Percentages p24gag1 ce
D of each band was determined and the ratio of P-Tyr/JAK1 was p
ctivation. CD41 T cells were infected with HIV-1 NL4-3 or IIIB, and a
immunoprecipitated (IP) with anti-JAK2 pAb. Nitrocellulose membrane w
stripped and immunoblotted with anti-JAK2 antibody (bottom). Percenta
espectively. The OD of each band was determined and the ratio of P-Ty
C) JAK1 and JAK2 expression. CD41 T cells were infected with NL4-3
Ab (top), anti-JAK2 pAb (middle), and then anti-actin mAb (bottom). Th
n HIV-infected T cells was compared to the level in uninfected T cells
s a representative experiment of three and the graphs are the average
etween NL4-3 and IIIB (for JAK1 expression P 5 0.184 and for JAK2ylation of STAT5 is completely inhibited in NL4-3-infected
T cells (Fig. 6B). These data support our hypothesis thatNL4-3 infection of T cells inhibits the JAK3/STAT5 activa-
ot affect expression or activation of JAK2. (A) JAK1 activation. CD41 T
ed and lysed and postnuclear supernatants were immunoprecipitated
ith anti-phosphotyrosine antibody (P-Tyr, top) and then stripped and
L4-3- and IIIB-infected cultures were 20.19 and 18.13, respectively. The
A representative experiment of three performed is shown. (B) JAK2
, cells were harvested and lysed and postnuclear supernatants were
unoblotted (IB) with anti-phosphotyrosine antibody (P-Tyr, top) and then
4gag1 cells in NL4-3- and IIIB-infected cultures were 25.67 and 40.75,
was plotted. A representative experiment of three performed is shown.
as in A. Cell lysates were analyzed by immunoblotting with anti-JAK1
f each band was determined and change in JAK1 or JAK2 protein level
lculated as described under Materials and Methods. The blot shown
M of three experiments. There is no statistically significant difference
sion P 5 0.178).does n
arvest
(IB) w
lls in N
lotted.
t day 6
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exprestion pathway by inhibiting JAK3 kinase activity and inhib-
iting the expression of JAK3 and STAT5 protein.
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417HIV-1 INFECTION AND JAK3/STAT5 ACTIVATIONNL4-3 does not inhibit STAT1 phosphorylation or
expression
Experiments were done to determine whether NL4-3
or IIIB infection of T cells inhibits tyrosine phosphoryla-
tion of a different STAT member, STAT1. PHA-activated
CD41 T cells were infected with HIV-1 NL4-3 or IIIB and
STAT1 phosphorylation was determined as described
under Materials and Methods. Briefly, postnuclear ly-
sates were immunoprecipitated with anti-STAT1 mAb
and immunoblotted with anti-phosphotyrosine antibody.
As shown in Fig. 7A, neither NL4-3 nor IIIB infection
inhibited tyrosine phosphorylation of STAT1. Numbers of
productively infected cells in NL4-3 and IIIB cultures
were similar.
Similar experiments were done to determine the ex-
pression of STAT1 in NL4-3- or IIIB-infected T cells.
STAT1 expression was determined by separating post-
nuclear lysates by SDS–PAGE and immunoblotting with
anti-STAT1 mAb and then with anti-actin mAb. The optical
density of each band was measured and the ratio of
STAT1/actin was graphed. As shown in Fig. 7B, neither
NL4-3 nor IIIB infection inhibited STAT1 expression.
These data suggest that NL4-3 specifically targets the
JAK3/STAT5 activation pathway.
DISCUSSION
FIG. 5. NL4-3, but not IIIB, inhibits STAT5 phosphorylation and expres
r IIIB as in Fig. 1A. Cell lysates were immunoprecipitated (IP) with
nti-phosphotyrosine antibody (P-Tyr, top) and then stripped and imm
etermined and the ratio of P-Tyr/STAT5 was plotted. p24gag1 cells in NL
experiment of three performed is shown. (B) STAT5 expression. CD41 T
y immunoblotting with anti-STAT5 antibody (top) and then the nitrocellu
he OD of each band was determined and change in STAT5 protein l
alculated as described under Materials and Methods. The blot show
our experiments. The asterisk represents a significant difference betwBiochemical mechanisms of HIV-1-induced T cell dys-
function and apoptosis remain controversial. Here, we
t
ashow that the JAK3/STAT5 activation pathway is inhibited
in CD41 T cells infected with NL4-3, while productive
infection with HIV-1 IIIB does not inhibit JAK3/STAT5
activation. Recent work from our laboratory has shown
that CD41 T cells productively infected with HIV-1 strain
IIIB have a lower number of apoptotic cells than CD41 T
ells productively infected with NL4-3 (Rapaport et al.,
998). Of note, the frequency of apoptotic IIIB-infected
ells is even less than that seen in uninfected cultures
Rapaport et al., 1998). Our earlier work analyzed apo-
tosis and infection in lymph nodes from HIV-infected
ndividuals, a major reservoir of viral infection. Surpris-
ngly, apoptosis was found predominantly in uninfected
ystander cells and not in productively infected cells
Finkel et al., 1995). While the work reported here did not
nalyze primary viral isolates, it is intriguing to speculate
hat these isolates behave like IIIB and inhibit apoptosis
n infected cells. The biological significance of the differ-
nce between the two T-tropic viruses is not known. We
ypothesize that a mutation(s) may have occurred in IIIB
hich protects the infected cells from apoptosis. Main-
enance of host cell viability would provide an advantage
o the virus by allowing production of more virions. The
iochemical mechanisms involved in inhibition of apo-
tosis by HIV-1 IIIB are not understood. As shown in Fig.
, the JAK3 protein level is higher in IIIB-infected T cells
han in uninfected T cells. Although the significance of
) STAT5 phosphorylation. CD41 T cells were infected with HIV-1 NL4-3
AT5 antibody. Nitrocellulose membrane was immunoblotted (IB) with
otted with anti-STAT5 antibody (bottom). The OD of each band was
d IIIB-infected cultures were 45 and 35%, respectively. A representative
ere infected with NL4-3 or IIIB as in Fig. 1A. Cell lysates were analyzed
mbrane was stripped and immunoblotted with anti-actin mAb (bottom).
HIV-infected T cells was compared to the level in uninfected T cells,
epresentative experiment of four and the graph is average 6 SEM of
L4-3 and IIIB (P 5 0.04).sion. (A
anti-ST
unobl
4-3- an
cells w
lose me
evel inhis higher JAK3 level is not known, we hypothesize that
ctivation of the JAK3/STAT5 pathway protects IIIB in-
k5
i
a
of JAK3
418 SELLIAH AND FINKELfected cells from apoptosis. Further work is needed to
test this hypothesis.
NL4-3-infected T cells show inhibition of JAK3 and
STAT5 activation and expression, which could lead to
inhibition of IL-2-mediated proliferation and survival sig-
nals. As shown in Fig. 3, inhibition of JAK3 expression
correlates with apoptosis. Moderate inhibition of JAK1
activation is seen in NL4-3- but not IIIB-infected T cells.
It has been reported recently that JAK3 phosphorylates
JAK1 (Zhou et al., 2000). This could explain the inhibition
of JAK1 tyrosine phosphorylation in NL4-3-infected T
cells. Interestingly, in contrast to JAK3, JAK1 protein ex-
pression is not inhibited in NL4-3-infected cells. Activa-
tion and expression of another Janus family kinase, JAK2,
are not inhibited in NL4-3-infected T cells, arguing
against a global inhibition of the JAKs. We hypothesize
that the defect in JAK3 activation leads to inhibition of
FIG. 6. NL4-3, but not IIIB, inhibits JAK3/STAT5 activation. (A) CD41
3 105 cells were incubated without or with 50 U/ml IL-2 at 37°C
mmunoblotting with phosphorylation-specific anti-STAT5 mAb (pSTAT5
nti-actin antibody (bottom). A representative experiment of two perform
15 min. Cells were lysed and postnuclear lysates were analyzed by imm
and immunoblotted with anti-JAK3, anti-STAT5, and then anti-actin anti
longer exposure). The OD of each band was determined and the ratios
experiment of two performed is shown.proliferation and induction of apoptosis in NL4-3-infected
T cells. The defect in JAK3 activation may also blockJAK1-mediated signaling; thus, JAK3 alone, or JAK3 and
JAK1, is inhibited in transducing signals for STAT5 phos-
phorylation and/or other survival pathways, e.g., the
PI3K/Akt cascade (Zhou et al., 2000). Collectively, these
data suggest that inhibition of the JAK3/JAK1/STAT5 ac-
tivation pathway may explain, at least in part, the apo-
ptosis seen in NL4-3-infected T cells. The biochemical
mechanism(s) of inhibition of JAK3 expression in NL4-3-
infected T cells is not understood. We hypothesize that
NL4-3 gene products and/or binding of free virions to
uninfected T cells are responsible for the JAK3 inhibition.
Nef has been shown to bind to and inhibit p56lck and ERK
inase activity (Greenway et al., 1996) and could, thus,
inhibit TCR/CD3-induced JAK3 expression. Experiments
are under way to test various NL4-3 gene products to
determine their roles in inhibition of JAK3 activation and
expression. Surprisingly, even a low level of NL4-3 infec-
were infected with NL4-3 or IIIB as in Fig. 1A. At day 6 postinfection,
min. Cells were lysed and postnuclear lysates were analyzed by
he nitrocellulose membrane was stripped and immunoblotted with an
shown. (B) 5 3 105 cells were incubated with 50 U/ml IL-2 at 37°C for
tting with anti-pSTAT5 mAb. The nitrocellulose membrane was stripped
The pSTAT5 blot was exposed to the film for longer times (pSTAT5—
, STAT5, pSTAT5/actin, or pSTAT5/STAT5 were plotted. A representativeT cells
for 15
, top). T
ed is
unoblo
bodies.tion inhibited JAK3 expression in T cells from infected
cultures (data not shown). In previous work, we have
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419HIV-1 INFECTION AND JAK3/STAT5 ACTIVATIONshown that increases in JAK3 expression and activation
induced by antigen receptor ligation are inhibited by
prior CD4 ligation by HIV gp120 or anti-CD4 mAb (Selliah
and Finkel, 1998). It is possible that, in our cultures, viral
particles or shed viral envelope protein ligated the CD4
receptor on uninfected cells, inducing a negative signal,
and inhibition of JAK3 expression. Thus, productive in-
fection of only a small number of T cells in HIV-infected
individuals could affect JAK3/STAT5 signaling of unin-
fected cells in vivo, leading to T cell dysfunction, death,
nd failure of regeneration of the T cell repertoire.
A reduced expression of STAT1a, STAT5A, and STAT5B
as been reported in T cells from HIV-seropositive indi-
iduals (Pericle et al., 1998). In addition, in vitro infection
with HIV-1 (strain BZ167) inhibits STAT5 expression, but
not STAT1 expression (Pericle et al., 1998), in agreement
with our findings (Figs. 5 and 7). In contrast, Bovolenta et
al. reported that HIV-1 did not inhibit STAT5 expression in
T cells (Bovolenta et al., 1999). Although the basis for this
discrepancy is not known, experimental differences be-
tween these studies include (1) analysis of different viral
isolates (which, as shown here, can give markedly dif-
ferent results) and (2) the use of resting PBMCs, a sys-
tem in which productive infection is limited (Unutmaz et
al., 1999). Interestingly, we have previously reported that
CD4 ligation of resting T cells by HIV gp120 inhibits
TCR/CD3-induced activation and expression of JAK3
FIG. 7. NL4-3 and IIIB did not inhibit STAT1 phosphorylation or expr
IIB as in Fig. 1A. Cell lysates were immunoprecipitated (IP) with
nti-phosphotyrosine antibody (P-Tyr, top) and then stripped and immu
nd IIIB-infected cultures were 26.29 and 23.73, respectively. The OD
epresentative experiment of three performed is shown. (B) STAT1 expre
were analyzed by immunoblotting with anti-STAT1 mAb (top) and then
mAb (bottom). Change in STAT1 protein level in HIV-infected T cells was
Materials and Methods. The blot shown is a representative experimen
is no statistically significant difference between NL4-3 and IIIB (P 5 0(Selliah and Finkel, 1998). Our unpublished data show
that CD4 ligation, without productive infection, inhibits
S
cSTAT5 activation, but does not inhibit STAT5 expression
(data not shown).
Our data suggest that productive infection with certain
strains of HIV-1 inhibits activation of the JAK3/STAT5
pathway and, thus, may inhibit resultant transcriptional
activation required for cell cycle progression, cell prolif-
eration, and survival. The biochemical mechanisms of
HIV-induced inhibition of the JAK3/STAT5 activation path-
way are under investigation. We have reported that de-
letion of nef, vpr, and vpu genes did not completely
escue NL4-3-infected cells from apoptosis (Rapaport et
l., 1998). We hypothesize that these gene products may
ot be the sole mediators of inhibition of the JAK3/STAT5
ctivation pathway. Recent data suggest that inhibition of
he JAK3/STAT5 activation pathway leads to inhibition of
urvival signals, possibly by failure of induction of Bcl-2
nd/or Bcl-XL (Nosaka et al., 1999; Suzuki et al., 2000). It
has been reported that Bcl-2 rescues T lymphopoiesis in
gc-deficient mice (Kondo et al., 1997). Binding of JAK3 to
gc is required for its activation and JAK3- and gc-defi-
cient mice show similar defects in T cell development
and activation (Suzuki et al., 2000). STAT5 activation has
been shown to upregulate Bcl-XL by binding to its pro-
moter (Horita et al., 2000). STAT5 activation is necessary
or cell cycle progression and antiapoptotic effects
Zamorano et al., 1998). Collectively, these data show a
orrelation between apoptosis and inhibition of the JAK3/
(A) STAT1 activation. CD41 T cells were infected with HIV-1 NL4-3 or
TAT1 mAb. Nitrocellulose membrane was immunoblotted (IB) with
ed with anti-STAT1 mAb (bottom). Percentages p24gag1 cells in NL4-3-
h band was determined and the ratio of P-Tyr/STAT1 was plotted. A
CD41 T cells were infected with NL4-3 or IIIB as in Fig. 1A. Cell lysates
ocellulose membrane was stripped and immunoblotted with anti-actin
red to the level in uninfected T cells and calculated as described under
ee and the graph is the average 6 SEM of three experiments. Thereession.
anti-S
noblott
of eac
ssion.
the nitr
compaTAT5 activation pathway and may, in part, explain the T
ell dysfunction and apoptosis seen in HIV disease.
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420 SELLIAH AND FINKELFurther experiments are under way to dissect the mech-
anistic differences between NL4-3 and IIIB in regulation
of the JAK3/STAT5 activation pathway and apoptosis.
MATERIALS AND METHODS
Isolation of CD41 T cells
Heparinized venous blood obtained from healthy adult
human donors was separated on a Ficoll–Paque (Phar-
macia Biotech, Piscataway, NJ) gradient to obtain lym-
phocytes. CD41 T cells were isolated by incubation with
anti-CD8 mAb (OKT8; ATCC, Manassas, VA), followed by
negative selection on goat anti-mouse IgG-coated Immu-
lan beads (Biotecx Laboratories, Houston, TX). Isolated
cells were 80–95% CD41 by flow cytometric analysis
(data not shown).
HIV-1 infection
Purified CD41 T cells (2 3 106 cells/ml) were activated
ith PHA (1.5 mg/ml; Murex Biotech Ltd., Kent, England)
for 3 days in RPMI 1640 culture media (Life Technologies,
Grand Island, NY) supplemented with 10% fetal bovine
serum (Gemini BioProducts, Calabas, CA). Cells (4 3
106) were incubated with HIV molecular clone NL4-3
obtained through NIH AIDS Research and Reference
eagent Program, Bethesda, MD) at multiplicity of infec-
ion (m.o.i.) of 0.05 or with HIV-1 strain IIIB (ABI, Colom-
ia, MD) at m.o.i. of 0.05 for 2 h at 37°C. Cells were
ashed once and resuspended at 1 3 106 cells/ml in
culture media with 20 U/ml interleukin-2 (R&D Systems,
Minneapolis, MN). The cell concentration was adjusted
to 1 3 106/ml every 2–3 days. Productive infection of T
cells was monitored by staining for expression of intra-
cytoplasmic protein, p24gag, with phycoerythrin-conju-
ated anti-p24 mAb (KC57-RD1; Coulter, Hialeah, FL).
In some experiments, after 4 days of infection with
L4-3 or IIIB, T cells were activated with anti-CD3 mAb.
hree hundred microliters of cells at 2 3 106 per milliliter
were added to a 24-well plate coated with anti-CD3 mAb
(ATCC). Cells were incubated for 24 h at 37°C, harvested,
and lysed for Western analysis as described below.
Immunoprecipitation and Western blotting
HIV-infected cells (5 3 106 cells) were harvested after
, 4, or 6 days of infection and lysed in Tris buffer
ontaining 1% NP-40, phosphatase inhibitors, and pro-
ease inhibitors. Postnuclear lysates were used for im-
unoprecipitation with the following antibodies in a se-
uential manner: anti-Jak1 polyclonal antibody (pAb; Up-
tate Biotechnology, Lake Placid, NY), anti-Jak2 pAb
Upstate Biotechnology), anti-JAK3 pAb (Santa Cruz Bio-
echnology, Santa Cruz, CA), anti-STAT1 mAb (Santa Cruz
iotechnology), and anti-STAT5 pAb (recognizes bothsoforms STAT5a and STAT5b; Santa Cruz Biotech-
ology). The antibody–protein complex was pelleted us-
Hng Sepharose-conjugated protein A (Sigma, St. Louis,
O) and boiled in sample buffer (0.4% SDS, 3% glycerol,
nd 1% b-mercaptoethanol (Sigma)) and the proteins
ere separated by 7.5% SDS–PAGE. The proteins were
ransferred to nitrocellulose membrane and immunoblot-
ed with anti-phosphotyrosine mAb (P-Tyr, Ab-2; Onco-
ene Science, Cambridge, MA). Positive protein bands
ere detected with horseradish peroxidase (HRP)-con-
ugated goat anti-mouse IgG (Jackson ImmunoResearch,
est Grove, PA) and SuperSignal Substrate (SSS; Pierce,
ockford, IL). Membranes were stripped with 62.5 mM
ris–HCl, pH 6.7, containing 10 mM b-mercaptoethanol
nd 2% SDS, immunoblotted with corresponding antibod-
es, and developed with HRP-conjugated protein A and
SS.
In other experiments, 1 3 106 cell equivalents of post-
uclear lysate were boiled with sample buffer and sep-
rated by 7.5% SDS–PAGE. Nitrocellulose membrane
as immunoblotted with the following antibodies: anti-
AK1 pAb, anti-JAK2 pAb, anti-JAK3 pAb, anti-STAT1 mAb,
nti-STAT5 pAb, phosphorylation-specific anti-STAT5
Ab (pSTAT5; Zymed, San Francisco, CA), or anti-actin
Ab (Sigma). The membrane was stripped between
ach immunoblotting as described above. Optical den-
ity of positive bands was measured with the Geldoc
000 (Bio-Rad, Hercules, CA).
Change in JAK3 protein level was calculated as fol-
ows:
OD of JAK3HIV 2 OD of JAK3MOCK
OD of JAK3MOCK
.
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